Novel therapy shows promise for lung cancer patients with rare EGFR mutation

Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins. Source

Leave a Reply

Your email address will not be published.